Motor and somatosensory evoked potentials are well maintained in patients given dexmedetomidine during spine surgery

Anesthesiology

Volumn 109, Issue 3, 2008, Pages 417-425

  Farag, Ehab ^b,c,f   Bala, Endrit ^a   Sessler, Daniel I ^a   Nair, Dileep R ^d   McLain, Robert ^b,c   Dalton, Jarrod E ^e  

^a Department of Outcomes Research ^*

^b CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d Epilepsy Center

^e Departments of Quantitative Health Sciences and Outcomes Research

^f Departments of General Anesthesia and Outcomes Research

Author keywords

[No Author keywords available]

Indexed keywords

DESFLURANE; DEXMEDETOMIDINE; PROPOFOL; REMIFENTANIL; ROCURONIUM; SUXAMETHONIUM; ANALGESIC AGENT; DRUG DERIVATIVE; INHALATION ANESTHETIC AGENT; INTRAVENOUS ANESTHETIC AGENT; ISOFLURANE; PIPERIDINE DERIVATIVE;

ADULT; AGED; AMPLITUDE MODULATION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; ELECTRIC POTENTIAL; EVOKED MUSCLE RESPONSE; EVOKED SOMATOSENSORY RESPONSE; HUMAN; INTRAOPERATIVE PERIOD; LATENT PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SPINE SURGERY; ADOLESCENT; AREA UNDER THE CURVE; DOSE RESPONSE; DRUG EFFECT; ELECTROCARDIOGRAPHY; FEMALE; MALE; MIDDLE AGED; REACTION TIME; SPINE;

ADOLESCENT; ADULT; AGED; ANALGESICS, NON-NARCOTIC; ANESTHETICS, INHALATION; ANESTHETICS, INTRAVENOUS; AREA UNDER CURVE; CROSS-OVER STUDIES; DEXMEDETOMIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; EVOKED POTENTIALS, MOTOR; EVOKED POTENTIALS, SOMATOSENSORY; FEMALE; HUMANS; ISOFLURANE; MALE; MIDDLE AGED; PIPERIDINES; REACTION TIME; SINGLE-BLIND METHOD; SPINE;

EID: 52649171309     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e318182a467     Document Type: Article

References (42)

1. Padberg AM, Wilson-Holden TJ, Lenke LG, Bridwell KH: Somatosensory- and motor-evoked potential monitoring without a wake-up test during idiopathic scoliosis surgery: An accepted standard of care. Spine 1998; 23:1392-400
2. Weinzierl MR, Reinacher P, Gilsbach JM, Rohde V: Combined motor and somatosensory evoked potentials for intraoperative monitoring: Intra- and postoperative data in a series of 69 operations. Neurosurg Rev 2007; 30:109-16
3. Ecker ML, Dormans JP, Schwartz DM, Drummond DS, Bulman WA: Efficacy of spinal cord monitoring in scoliosis surgery in patients with cerebral palsy. J Spinal Disord 1996; 9:159-64
4. Noordeen MH, Lee J, Gibbons CE, Taylor BA, Bentley G: Spinal cord monitoring in operations for neuromuscular scoliosis. J Bone Joint Surg Br 1997; 79:53-7
5. Nuwer MR, Dawson EG, Carlson LG, Kanim LE, Sherman JE: Somatosensory evoked potential spinal cord monitoring reduces neurologic deficits after scoliosis surgery: Results of a large multicenter survey. Electroencephalogr Clin Neurophysiol 1995; 96:6-11
6. Thuet ED, Padberg AM, Raynor BL, Bridwell KH, Riew KD, Taylor BA, Lenke LG: Increased risk of postoperative neurologic deficit for spinal surgery patients with unobtainable intraoperative evoked potential data. Spine 2005; 30:2094-103
7. Lyon R, Lieberman JA, Grabovac MT, Hu S: Strategies for managing decreased motor evoked potential signals while distracting the spine during correction of scoliosis. J Neurosurg Anesthesiol 2004; 16:167-70
8. Banoub M, Tetzlaff JE, Schubert A: Pharmacologic and physiologic influences affecting sensory evoked potentials: Implications for perioperative monitoring. ANESTHESIOLOGY 2003; 99:716-37
9. Kalkman CJ, Drummond JC, Ribberink AA: Low concentrations of isoflurane abolish motor evoked responses to transcranial electrical stimulation during nitrous oxide/opioid anesthesia in humans. Anesth Analg 1991; 73:410-5
10. Kalkman CJ, Drummond JC, Ribberink AA, Patel PM, Sano T, Bickford RG: Effects of propofol, etomidate, midazolam, and fentanyl on motor evoked responses to transcranial electrical or magnetic stimulation in humans. ANESTHESIOLOGY 1992; 76:502-9
11. Lam AM, Sharar SR, Mayberg TS, Eng CC: Isoflurane compared with nitrous oxide anaesthesia for intraoperative monitoring of somatosensory-evoked potentials. Can J Anaesth 1994; 41:295-300
12. Langeron O, Vivien B, Paqueron X, Saillant G, Riou B, Coriat P, Lille F: Effects of propofol, propofol-nitrous oxide and midazolam on cortical somatosensory evoked potentials during sufentanil anaesthesia for major spinal surgery. Br J Anaesth 1999; 82:340-5
13. Liu EH, Wong HK, Chia CP, Lim HJ, Chen ZY, Lee TL: Effects of isoflurane and propofol on cortical somatosensory evoked potentials during comparable depth of anaesthesia as guided by bispectral index. Br J Anaesth 2005; 94:193-7
14. Lotto ML, Banoub M, Schubert A: Effects of anesthetic agents and physiologic changes on intraoperative motor evoked potentials. J Neurosurg Anesthe-siol 2004; 16:32-42
15. Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD: The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiol-ogy 2000; 93:382-94
16. Aantaa R, Jaakola ML, Kallio A, Kanto J: Reduction of the minimum alveolar concentration of isoflurane by dexmedetomidine. ANESTHESIOLOGY 1997; 86:1055-60
17. Aantaa R, Kanto J, Scheinin M, Kallio A, Scheinin H: Dexmedetomidine, an alpha 2-adrenoceptor agonist, reduces anesthetic requirements for patients undergoing minor gynecologic surgery. ANESTHESIOLOGY 1990; 73:230-5
18. Arain SR, Ebert TJ: The efficacy, side effects, and recovery characteristics of dexmedetomidine versus propofol when used for intraoperative sedation. Anesth Analg 2002; 95:461-6
19. Gurbet A, Basagan-Mogol E, Turker G, Ugun F, Kaya FN, Ozcan B: Intraoperative infusion of dexmedetomidine reduces perioperative analgesic requirements. Can J Anaesth 2006; 53:646-52
20. Li BH, Lohmann JS, Schuler HG, Cronin AJ: Preservation of the cortical somatosensory-evoked potential during dexmedetomidine infusion in rats. Anesth Analg 2003; 96:1155-60
21. Bloom M, Beric A, Bekker A: Dexmedetomidine infusion and somatosensory evoked potentials. J Neurosurg Anesthesiol 2001; 13:320-2
22. Haenggi M, Ypparila H, Hauser K, Caviezel C, Korhonen I, TakalaJ, Jakob SM: The effects of dexmedetomidine/remifentanil and midazolam/remifentanil on auditory-evoked potentials and electroencephalogram at light-to-moderate sedation levels in healthy subjects. Anesth Analg 2006; 103:1163-9
23. Mahmoud M, Sadhasivam S, Sestokas AK, Samuels P, McAuliffe J: Loss of transcranial electric motor evoked potentials during pediatric spine surgery with dexmedetomidine. ANESTHESIOLOGY 2007; 106:393-6
24. Thornton C, Lucas MA, Newton DE, Dore CJ, Jones RM: Effects of dexmedetomidine on isoflurane requirements in healthy volunteers, 2: Auditory and somatosensory evoked responses. Br J Anaesth 1999; 83:381-6
25. Talke P, Richardson CA, Scheinin M, Fisher DM: Postoperative pharmacokinetics and sympatholytic effects of dexmedetomidine. Anesth Analg 1997; 85:1136-42
26. Guideline nine: Guidelines on evoked potentials. American Electroencephalographic Society. J Clin Neurophysiol 1994; 11:40-73
27. Guideline twelve: Guidelines for long-term monitoring for epilepsy. American Electroencephalographic Society. J Clin Neurophysiol 1994; 11:88-110
28. Guideline thirteen: Guidelines for standard electrode position nomenclature. American Electroencephalographic Society. J Clin Neurophysiol 1994; 11: 111-3
29. Guideline fourteen: Guidelines for recording clinical EEG on digital media. American Electroencephalographic Society. J Clin Neurophysiol 1994; 11:114-5
30. Calancie B, Harris W, BrotonJG, AlexeevaN, Green BA: "Threshold- level" multipulse transcranial electrical stimulation of motor cortex for intraoperative monitoring of spinal motor tracts: Description of method and comparison to somatosensory evoked potential monitoring. J Neurosurg 1998; 88:457-70
31. Schuirmann DJ: A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J Pharmacokinet Biopharm 1987; 15:657-80
32. Samra SK, Dy EA, Welch KB, Lovely LK, Graziano GP: Remifentanil- and fentanyl-based anesthesia for intraoperative monitoring of somatosensory evoked potentials. Anesth Analg 2001; 92:1510-5
33. Aantaa R, Scheinin M: Alpha 2-adrenergic agents in anaesthesia. Acta Anaesthesiol Scand 1993; 37:433-48
34. Hayashi Y, Maze M: Alpha 2 adrenoceptor agonists and anaesthesia. Br J Anaesth 1993; 71:108-18
35. Engelhard K, Werner C, Eberspacher E, Bachl M, Blobner M, Hildt E, Hutzler P, Kochs E: The effect of the alpha 2-agonist dexmedetomidine and the N-methyl-D-aspartate antagonist S(+)-ketamine on the expression of apoptosisregulating proteins after incomplete cerebral ischemia and reperfusion in rats. Anesth Analg 2003; 96:524-31
36. KuhmonenJ, PokornyJ, MiettinenR, HaapalinnaA, JolkkonenJ, Riekkinen P Sr, Sivenius J: Neuroprotective effects of dexmedetomidine in the gerbil hippocampus after transient global ischemia. ANESTHESIOLOGY 1997; 87:371-7
37. Ma D, Hossain M, Rajakumaraswamy N, Arshad M, Sanders RD, Franks NP, Maze M: Dexmedetomidine produces its neuroprotective effect via the alpha 2A-adrenoceptor subtype. Eur J Pharmacol 2004; 502:87-97
38. Maier C, Steinberg GK, Sun GH, Zhi GT, Maze M: Neuroprotection by the alpha 2-adrenoreceptor agonist dexmedetomidine in a focal model of cerebral ischemia. ANESTHESIOLOGY 1993; 79:306-12
39. Paris A, Mantz J, Tonner PH, Hein L, Brede M, Gressens P: The effects of dexmedetomidine on perinatal excitotoxic brain injury are mediated by the alpha2A-adrenoceptor subtype. Anesth Analg 2006; 102:456-61
40. Bol C, Danhof M, Stanski DR, MandemaJW: Pharmacokinetic-pharmacodynamic characterization of the cardiovascular, hypnotic, EEG and ventilatory responses to dexmedetomidine in the rat. J Pharmacol Exp Ther 1997; 283: 1051-8
41. Koroglu A, Demirbilek S, Teksan H, Sagir O, But AK, Ersoy MO: Sedative, haemodynamic and respiratory effects of dexmedetomidine in children undergoing magnetic resonance imaging examination: Preliminary results. Br J Anaesth 2005; 94:821-4
42. Hsu YW, Cortinez LI, Robertson KM, Keifer JC, Sum-Ping ST, Moretti EW, Young CC, Wright DR, Macleod DB, SommaJ: Dexmedetomidine pharmacodynamics, part I: Crossover comparison of the respiratory effects of dexmedetomidine and remifentanil in healthy volunteers. ANESTHESIOLOGY 2004; 101:1066-76